[Taking benzodiazepine is associated with an increased risk of Alzheimer disease].

Praxis (Bern 1994)

Horten-Zentrum für praxisorientierte Forschung und Wissenstransfer, Universitätsspital Zürich.

Published: December 2014

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a001871DOI Listing

Publication Analysis

Top Keywords

[taking benzodiazepine
4
benzodiazepine associated
4
associated increased
4
increased risk
4
risk alzheimer
4
alzheimer disease]
4
[taking
1
associated
1
increased
1
risk
1

Similar Publications

Impact of potentially inappropriate medications on emergency ambulance admissions in geriatric patients after discharge.

Pharmazie

December 2024

Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.

This study aimed to determine the risk of emergency admission by ambulance in patients taking potentially inappropriate medications (PIMs). We included 273,932 patients aged over 75 years of age admitted between January 1, 2019, and December 31, 2019, using the Japan Medical Data Center medical insurance database containing anonymized patient data. We excluded patients without a history of admission.

View Article and Find Full Text PDF

Objective: We aimed to investigate the effectiveness of buspirone as an adjunctive therapy for alleviating anxiety symptoms in patients with depressive disorders who are already taking antidepressants.

Methods: This was an open-label prospective multicenter non-interventional observational study conducted over 12 weeks. We enrolled 180 patients diagnosed with depressive disorders according to DSM-5 criteria and Hamilton Anxiety Rating Scale (HAMA) scores ≥ 18.

View Article and Find Full Text PDF

Drug overdose deaths among women 1999-2021 in the United States: Differences by race, ethnicity, and age.

Womens Health (Lond)

December 2024

Department of Human Development and Family Studies and Family Studies, The Pennsylvania State University, University Park, PA, USA.

Background: The U.S. drug overdose epidemic is increasingly severe and steep increases have been seen among women.

View Article and Find Full Text PDF

Background: Alterations in brain function and structure, such as depression and neurocognitive impairment, continue to occur in people with human immunodeficiency virus (HIV, PWH) taking suppressive antiretroviral therapy (ART). The lifespan of PWH has improved but the healthspan remains worse than people without HIV, in part because of aging-related diseases. As a result, polypharmacy is common and increases the risk of drug-drug interactions and adverse reactions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!